Walker on Progress

A new partnership brings enterprise-grade governance to AI-generated code, aiming to solve the growing security blind spot in automated software development.

Cytovance Biologics' new cell line service boasts top-tier yields. This strategic shift toward a 'one-stop-shop' model could redefine speed and cost in biopharma.

A partnership at Germany's largest battery site reveals a critical truth: the future of renewable energy depends as much on smart software as on hardware.

FlexPoint has launched AI-powered AR Agents to automate billing for MSPs, a move that addresses chronic cash flow issues and signals a broader shift toward autonomous back-office operations.

The tech-first insurer enters the Peace Garden State, betting its AI-powered app, low prices, and B-Corp mission can reshape a traditional market.

A new AssetMark study reveals many advisors' gains are just market lift. The real winners are building systems for hiring, referrals, and accountability.

Consumers demand eco-friendly cleaners but fear they don't work. A new brand, backed by a 74-year legacy, claims its enzyme-based science can finally deliver.

Kalmar partners with Syncron, replacing legacy systems with an AI-driven parts platform. The move aims to boost uptime, dealer efficiency, and service revenue.

As AI pushes data centers to their thermal limits, one company's pivot from product-maker to systems partner reveals the future of mission-critical validation.

A new campaign frames fusion energy as a U.S.-China security race. But beyond the hype, what is the reality of the global push for limitless power?

BioCardia secures a crucial $4.4M, extending its runway for a key Japan submission. But a closer look reveals a high-stakes bet on future warrant exercises.

Beta Bionics faces a shareholder investigation after a slowdown in patient growth spooked investors. We decode the numbers and the broader risks of growth metrics.

Hong Kong's NatureU touts impressive anti-aging results on a public registry, but a closer look reveals a complex strategy blending early science with savvy marketing.

A recall of Target's popular baby wipes over dangerous bacteria raises critical questions about private label safety, supplier oversight, and consumer trust.

Horizon Growth's new CEO isn't just a management change; it's the final piece in a year-long transformation from a niche carbon firm to a diversified investor.

With 21 banks and a $75B target, the SpaceX IPO isn't just big; it's a new blueprint. We dissect how Starlink's profit engine is funding a new model for mega-listings.

A new firm offers up to $250k in funded accounts for prediction market traders, a move that could professionalize a booming sector. But can it navigate the complex regulatory field?

A new report reveals a staggering $1.77 trillion societal cost from crashes. Beyond the stats lies a story of behavioral shifts and systemic failures.

Kyivstar's Uklon acquires scooter operator E-wings for $2.2M, a strategic move to build a mobility 'super-app' and pave the way for an autonomous future.

The WaveFly 5X promises personal flight over water. We dissect the tech, the market potential, and the massive regulatory challenges facing this bold new venture.